Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 9 de 9
Filtre
1.
Indian J Med Microbiol ; 2016 Oct-Dec; 34(4): 520-525
Article Dans Anglais | IMSEAR | ID: sea-181121

Résumé

The antimicrobial trends over 6 years were studied, and the effect of revised Clinical Laboratory Standards Institute (CLSI) breakpoints (2012) for ciprofloxacin susceptibility reporting in typhoidal Salmonellae was determined. A total of 874 (95.4%) isolates were nalidixic acid‑resistant (NAR). Using the CLSI 2011 guidelines (M100‑S21), 585 (66.9%) isolates were ciprofloxacin susceptible. The susceptibility reduced to 11 (1.25%) isolates when interpreted using 2012 guidelines (M100‑S22). Among the forty nalidixic acid susceptible (NAS) Salmonellae, susceptibility to ciprofloxacin decreased from 37 isolates (M100‑S21) to 12 isolates (M100‑S22). The 25 cases which appeared resistant with newer guidelines had a minimum inhibitory concentration (MIC) range between 0.125 and 0.5 μg/ml. MIC50 for the third generation cephalosporins varied between 0.125 and 0.5 μg/ml over 6 years whereas MIC90 varied with a broader range of 0.19–1 μg/ml. The gap between NAR and ciprofloxacin‑resistant strains identified using 2011 guidelines has been reduced; however, it remains to be seen whether additional NAS, ciprofloxacin‑resistant isolates are truly resistant to ciprofloxacin by other mechanisms of resistance.

2.
Indian J Med Microbiol ; 2015 Apr; 33(2): 305-307
Article Dans Anglais | IMSEAR | ID: sea-159558

Résumé

Bordetella trematum spp. nov. has been isolated from wounds, ear infections and diabetic ulcers. We report a case of a 7‑month‑old infant with fever, vomiting and abnormal body movements with bacteremia caused by this novel species. The infant responded to fluoroquinolone and macrolide combination therapy.

6.
Indian J Med Sci ; 1994 Dec; 48(12): 277-83
Article Dans Anglais | IMSEAR | ID: sea-68028

Résumé

1. This study was undertaken to assess whether the analgesia conferred by Diclofenac sodium in the post operative period following general surgery is enhanced by preoperative administration of the drug. 2. Two groups of patients were studied. Group I patients received narcotic premedication and Group II patients received Diclofenac sodium as premedication. Post operatively both groups were administered intramuscular Diclofenac sodium 8 hourly for 48 hours. 3. Pain scoring using visual analogue scale indicated a better pain relief in Group II patients. In Group I, 75% patients had a pain score less than 3 whereas 85% in Group II had a pain score less than 3 (Figure 1). 4. Pulmonary function tests were done 24 hours after surgery and revealed improved values of all parameters in Group II patients. This indicates a greater degree of analgesia in Group II patients. 5. Preoperative administration of the drug reduces the initiation of pain in the periphery and decreases the inflammatory response after surgery. 6. NSAIDS do not have any central effect or any respiratory depression. Patients in our study were found to be awake, cooperative and pain free. The additional analgesia conferred by preoperative administration in conjunction with adequate postoperative therapy allows us to recommend Diclofenac sodium as a sole analgesic for perioperative pain relief except in those patients with a bleeding diathesis.


Sujets)
Adulte , Atropine/usage thérapeutique , Diclofenac/usage thérapeutique , Femelle , Humains , Mâle , Péthidine/usage thérapeutique , Adulte d'âge moyen , Monitorage physiologique , Mesure de la douleur , Douleur postopératoire/traitement médicamenteux , Prémédication , Prométhazine/usage thérapeutique , Tests de la fonction respiratoire
7.
Article Dans Anglais | IMSEAR | ID: sea-20910

Résumé

With a view to assess the efficacy of intrathecal pentazocine for post-operative pain relief, 60 patients randomly divided into 6 equal groups were administered graded doses (0, 1, 2, 3, 4 and 5 mg respectively) of pentazocine lactate, intrathecally along with 1 per cent bupivacaine. The duration of analgesia was found to be dose related till 3 mg. Higher doses did not increase the duration of analgesia nor were any untoward effects observed. It is concluded that intrathecal pentazocine is safe and effective for post-operative pain relief and 3 mg is the minimum effective dose without side effect.


Sujets)
Adolescent , Adulte , Sujet âgé , Relation dose-effet des médicaments , Humains , Injections rachidiennes , Adulte d'âge moyen , Douleur postopératoire/traitement médicamenteux , Pentazocine/administration et posologie , Facteurs temps
SÉLECTION CITATIONS
Détails de la recherche